Condition: Poliomyelitis · Sponsor: Sinovac Biotech Co., Ltd
The goal of this clinical study is to compare the immunogenicity and safety of one dose of sIPV in adolescents or adults aged 7-50 years with that of three doses of DTaP-IPV-Hib Pentavalent Vaccine in Infants Aged 3 Months
This description comes directly from the study's public registry record.
Xiaoshu Zhang · 86-0931-8277391 · zhxs000@126.com
Always discuss trial participation with your own doctor first.
| Longxi County Center for Disease Prevention and Control, Dingxi City | Dingxi, Gansu, China | Recruiting |
| Chengguan District Center for Disease Prevention and Control, Lanzhou City | Lanzhou, Gansu, China | Recruiting |
| Zhangye Center for Disease Prevention and Control | Zhangye, Gansu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07354269